You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 121 No. 1, January 1985 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  STUDIES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Antiandrogenic Effects of Topically Applied Spironolactone on the Hamster Flank Organ

Arthur Weissmann, MD; Jeffrey Bowden, MD; Beryn L. Frank; Stephen N. Horwitz, MD; Phillip Frost, MD

Arch Dermatol. 1985;121(1):57-62.


Abstract



• The effects of topically applied spironolactone on the sebaceous glands of flank organs in adult male golden hamsters were investigated. Daily treatment with spironolactone (0.3 mg and 3 mg) on one side only significantly reduced the size of the treated flank organs, while the contralateral flank organs remained unchanged. Lower doses of spironolactone and the vehicle had no effect. Cyproterone acetate therapy resulted in the bilateral reduction of flank organ sizes. In vivo measurement of the palpable bulk of the flank organs correlated with flank organ volumes as determined by computer-assisted planimetry of serial histologic sections. Dry weights of seminal vesicles in animals treated with spironolactone did not differ significantly from those of the control group, while topically applied cyproterone acetate significantly reduced seminal vesicle weight. Topically administered spironolactone appears to have only local antiandrogenic effects, as indicated by the lack of changes in the untreated contralateral flank organs and in the weights of seminal vesicles.

(Arch Dermatol 1985;121:57-62)



Author Affiliations



From the Departments of Dermatology (Drs Weissmann, Bowden, Horwitz, and Frost) and Pathology (Ms Frank), Mount Sinai Medical Center, Miami Beach, Fla.


Footnotes



Accepted for publication Feb 22, 1984.

Presented at the Joint International Meeting of the Society for Investigative Dermatology and the European Society for Dermatological Research, Washington, DC, April 27-May 1, 1983.

Reprint requests to the Department of Dermatology, Mount Sinai Medical Center, 4300 Alton Rd, Miami Beach, FL 33140 (Dr Weissmann).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inocoterone and Acne: The Effect of a Topical Antiandrogen: Results of a Multicenter Clinical Trial
Lookingbill et al.
Arch Dermatol 1992;128:1197-1200.
ABSTRACT  

Antiandrogens and Acne: A Topical Approach?
Cunliffe and Bottomley
Arch Dermatol 1992;128:1261-1264.
ABSTRACT  

Topical Minoxidil Does Not Act as an Antiandrogen in the Flank Organ of the Golden Syrian Hamster
Nuck et al.
Arch Dermatol 1987;123:59-61.
ABSTRACT  

Topical Antiandrogens: What Use in Dermatology?
Lucky
Arch Dermatol 1985;121:55-56.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.